Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Laura Ridolfi, Francesco de Rosa, Ruggero Ridolfi, Giorgia Gentili, Linda Valmorri, Emanuela Scarpi, Elisabetta Parisi, Antonino Romeo, Massimo Guidoboni

ABSTRACT

BACKGROUND: Tumor cells killed by radiation therapy (RT) are a potentially good source of antigens for dendritic cell (DC) uptake and presentation to T-cells. RT upregulates cell death receptors such as Fas/CD95 and MHC-I, induces the expression of co-stimulatory molecules on tumor cells, and promotes production of pro-inflammatory cytokines. High-dose interleukin-2 (HD-IL-2) bolus has been shown to obtain objective response rates ranging from 15% to 17% in patients with metastatic melanoma or renal cell carcinoma (RCC), with 6% to 8% of cases experiencing a durable complete response. However, HD-IL-2 is also associated with severe side-effects; if it is to remain a component of the curative treatment strategy in patients with metastatic melanoma or RCC, its therapeutic efficacy must be improved and patients who are most likely to benefit from treatment must be identified a priori. We designed a clinical study combining immunomodulating RT and HD-IL-2 to evaluate their clinical and immunological efficacy and to explore the predictive and prognostic value of 1) tumor-specific immune response and 2) serum levels of proangiogenic cytokines. METHODS/DESIGN: The primary endpoint of this proof-of-principle phase II study is immune response. Secondary endpoints are the identification of biomarkers potentially predictive of response, toxicity, response rate and overall survival. Three daily doses of booster radiotherapy (XRT) at 6-12 Gy will be administered to at least one metastatic field on days -3 to -1 before the first and third cycle. Treatment with IL-2 (dose 18 MIU/m2/day by continuous IV infusion for 72 hours) will start on day +1 and will be repeated every 3 weeks for up to 4 cycles and then every 4 weeks for a further 2 cycles. Immune response against tumor antigens expressed by melanoma and/or RCC will be evaluated during treatment. Circulating immune effectors and regulators, e.g. cytotoxic T lymphocytes and regulatory T cells, as well as serum levels of proangiogenic/proinflammatory cytokines will also be quantified. DISCUSSION: This study aims to evaluate the potential immunological synergism between HD-IL-2 and XRT, and to identify biomarkers that are predictive of response to IL-2 in order to spare potentially non responding patients from toxicity. TRIAL REGISTRATION: EudraCT no. 2012-001786-32. More... »

PAGES

262

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12967-014-0262-6

DOI

http://dx.doi.org/10.1186/s12967-014-0262-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016280681

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25245327


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sample Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ridolfi", 
        "givenName": "Laura", 
        "id": "sg:person.01163341772.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163341772.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Rosa", 
        "givenName": "Francesco", 
        "id": "sg:person.01033414110.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033414110.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ridolfi", 
        "givenName": "Ruggero", 
        "id": "sg:person.01050453536.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gentili", 
        "givenName": "Giorgia", 
        "id": "sg:person.01362577760.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362577760.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valmorri", 
        "givenName": "Linda", 
        "id": "sg:person.01020727237.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020727237.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scarpi", 
        "givenName": "Emanuela", 
        "id": "sg:person.0707623076.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707623076.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Radiotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parisi", 
        "givenName": "Elisabetta", 
        "id": "sg:person.0643034760.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643034760.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Radiotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Romeo", 
        "givenName": "Antonino", 
        "id": "sg:person.0660433404.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660433404.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Immunotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guidoboni", 
        "givenName": "Massimo", 
        "id": "sg:person.0603211266.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603211266.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.immuni.2007.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002629248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002732031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-9-204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002969174", 
          "https://doi.org/10.1186/1479-5876-9-204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-1525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003315567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.1106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005654736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.0766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006224899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1471-4906(01)01860-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007002305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djs629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007220641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaci.2009.09.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012815377"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1002011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012824919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200107000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013282290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200107000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013282290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni1102-991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013709887", 
          "https://doi.org/10.1038/ni1102-991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni1102-991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013709887", 
          "https://doi.org/10.1038/ni1102-991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-2776(06)92005-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014165029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015678740"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.smim.2010.03.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017765338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2008.07435.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020644032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-3080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021277346"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.86.24.10104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025542654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1872", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025832682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/sj.embor.7401099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028445502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-1624", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028571226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2003.09.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028641767"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1440-1711.1999.00824.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032221856", 
          "https://doi.org/10.1046/j.1440-1711.1999.00824.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.1540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032602654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1961", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034368267", 
          "https://doi.org/10.1038/nri1961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1961", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034368267", 
          "https://doi.org/10.1038/nri1961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000177999.95831.7b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035482259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000177999.95831.7b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035482259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000177999.95831.7b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035482259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4402148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035848769", 
          "https://doi.org/10.1038/sj.cdd.4402148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4402148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035848769", 
          "https://doi.org/10.1038/sj.cdd.4402148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.immunol.26.021607.090357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039191682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041864150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2006.06.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042465078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/cgc.2005.n.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043681253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.03.6830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045493910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-11-54", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049399339", 
          "https://doi.org/10.1186/1479-5876-11-54"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19960101)77:1<89::aid-cncr15>3.0.co;2-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049715364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/09553000701481816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051306626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.06.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052313527"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(02)03748-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053539797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(02)03748-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053539797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/1084978041424972", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059207859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199809000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060134855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199809000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060134855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199809000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060134855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.276.5316.1268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062556793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1758834012443725", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1758834012443725", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1667/rr3196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068196266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1381612023394089", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069164659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/3578216", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070380764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.7.2105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074593980", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074593989", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075012417", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.7.1233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078157437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078776563", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079645830", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1995.13.3.688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082550218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082996261", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "BACKGROUND: Tumor cells killed by radiation therapy (RT) are a potentially good source of antigens for dendritic cell (DC) uptake and presentation to T-cells. RT upregulates cell death receptors such as Fas/CD95 and MHC-I, induces the expression of co-stimulatory molecules on tumor cells, and promotes production of pro-inflammatory cytokines. High-dose interleukin-2 (HD-IL-2) bolus has been shown to obtain objective response rates ranging from 15% to 17% in patients with metastatic melanoma or renal cell carcinoma (RCC), with 6% to 8% of cases experiencing a durable complete response. However, HD-IL-2 is also associated with severe side-effects; if it is to remain a component of the curative treatment strategy in patients with metastatic melanoma or RCC, its therapeutic efficacy must be improved and patients who are most likely to benefit from treatment must be identified a priori. We designed a clinical study combining immunomodulating RT and HD-IL-2 to evaluate their clinical and immunological efficacy and to explore the predictive and prognostic value of 1) tumor-specific immune response and 2) serum levels of proangiogenic cytokines.\nMETHODS/DESIGN: The primary endpoint of this proof-of-principle phase II study is immune response. Secondary endpoints are the identification of biomarkers potentially predictive of response, toxicity, response rate and overall survival. Three daily doses of booster radiotherapy (XRT) at 6-12 Gy will be administered to at least one metastatic field on days -3 to -1 before the first and third cycle. Treatment with IL-2 (dose 18 MIU/m2/day by continuous IV infusion for 72 hours) will start on day +1 and will be repeated every 3 weeks for up to 4 cycles and then every 4 weeks for a further 2 cycles. Immune response against tumor antigens expressed by melanoma and/or RCC will be evaluated during treatment. Circulating immune effectors and regulators, e.g. cytotoxic T lymphocytes and regulatory T cells, as well as serum levels of proangiogenic/proinflammatory cytokines will also be quantified.\nDISCUSSION: This study aims to evaluate the potential immunological synergism between HD-IL-2 and XRT, and to identify biomarkers that are predictive of response to IL-2 in order to spare potentially non responding patients from toxicity.\nTRIAL REGISTRATION: EudraCT no. 2012-001786-32.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12967-014-0262-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response", 
    "pagination": "262", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4d92fb5f788e886822218ed4c772e4965d2be8d5beac092fdcfa1382fd0d1a1d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25245327"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12967-014-0262-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016280681"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12967-014-0262-6", 
      "https://app.dimensions.ai/details/publication/pub.1016280681"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88221_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12967-014-0262-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0262-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0262-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0262-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0262-6'


 

This table displays all metadata directly associated to this object as RDF triples.

333 TRIPLES      21 PREDICATES      94 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12967-014-0262-6 schema:about N142d433b7c6348a7905bdb4e07ddb2f7
2 N2c6da7b9b7a24a5a82d040463a23c6d7
3 N568d25d8c4f74a1596376701ec29254c
4 N5f414b0220b5465cb1e1c981f34bee70
5 N67eaae53e5cd4ca9b4249da2f9722d67
6 N703f3c50072b464fb7caa9e0564a3c6c
7 N72dc1a4140784d3ab9c5899220ab5929
8 N910d2d1b41924526ad3a34020733c452
9 N973eb2c5f71e45b79864670a75fa314e
10 N988819765a204143b10050226df736dc
11 Na9ef8ad73ff44052b2e82018a679956e
12 Nda0c5a427d49467c935d3837c603cacc
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nca76ae52ba0649c08b0027a3cd528641
16 schema:citation sg:pub.10.1038/ni1102-991
17 sg:pub.10.1038/nri1961
18 sg:pub.10.1038/sj.cdd.4402148
19 sg:pub.10.1046/j.1440-1711.1999.00824.x
20 sg:pub.10.1186/1479-5876-11-54
21 sg:pub.10.1186/1479-5876-9-204
22 https://app.dimensions.ai/details/publication/pub.1074593980
23 https://app.dimensions.ai/details/publication/pub.1074593989
24 https://app.dimensions.ai/details/publication/pub.1075012417
25 https://app.dimensions.ai/details/publication/pub.1078776563
26 https://app.dimensions.ai/details/publication/pub.1079645830
27 https://app.dimensions.ai/details/publication/pub.1082996261
28 https://doi.org/10.1002/(sici)1097-0142(19960101)77:1<89::aid-cncr15>3.0.co;2-4
29 https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m
30 https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k
31 https://doi.org/10.1016/j.ijrobp.2003.09.012
32 https://doi.org/10.1016/j.ijrobp.2005.06.032
33 https://doi.org/10.1016/j.immuni.2007.02.009
34 https://doi.org/10.1016/j.jaci.2009.09.045
35 https://doi.org/10.1016/j.smim.2010.03.001
36 https://doi.org/10.1016/s0065-2776(06)92005-7
37 https://doi.org/10.1016/s0360-3016(02)03748-3
38 https://doi.org/10.1016/s1471-4906(01)01860-9
39 https://doi.org/10.1038/sj.embor.7401099
40 https://doi.org/10.1053/j.seminoncol.2006.06.004
41 https://doi.org/10.1056/nejmoa1002011
42 https://doi.org/10.1056/nejmoa1103782
43 https://doi.org/10.1073/pnas.86.24.10104
44 https://doi.org/10.1080/09553000701481816
45 https://doi.org/10.1089/1084978041424972
46 https://doi.org/10.1093/jnci/djs629
47 https://doi.org/10.1097/00000658-199809000-00004
48 https://doi.org/10.1097/00002371-200107000-00004
49 https://doi.org/10.1097/01.cji.0000177999.95831.7b
50 https://doi.org/10.1111/j.1464-410x.2008.07435.x
51 https://doi.org/10.1126/science.276.5316.1268
52 https://doi.org/10.1146/annurev.immunol.26.021607.090357
53 https://doi.org/10.1158/0008-5472.can-04-1525
54 https://doi.org/10.1158/1078-0432.ccr-06-1872
55 https://doi.org/10.1158/1078-0432.ccr-09-1624
56 https://doi.org/10.1158/1078-0432.ccr-12-3080
57 https://doi.org/10.1177/1758834012443725
58 https://doi.org/10.1200/jco.1991.9.7.1233
59 https://doi.org/10.1200/jco.1995.13.3.688
60 https://doi.org/10.1200/jco.1999.17.7.2105
61 https://doi.org/10.1200/jco.2005.03.6830
62 https://doi.org/10.1200/jco.2008.19.1106
63 https://doi.org/10.1200/jco.2008.20.0766
64 https://doi.org/10.1200/jco.2008.21.1540
65 https://doi.org/10.1667/rr3196
66 https://doi.org/10.2174/1381612023394089
67 https://doi.org/10.2307/3578216
68 https://doi.org/10.3816/cgc.2005.n.030
69 schema:datePublished 2014-12
70 schema:datePublishedReg 2014-12-01
71 schema:description BACKGROUND: Tumor cells killed by radiation therapy (RT) are a potentially good source of antigens for dendritic cell (DC) uptake and presentation to T-cells. RT upregulates cell death receptors such as Fas/CD95 and MHC-I, induces the expression of co-stimulatory molecules on tumor cells, and promotes production of pro-inflammatory cytokines. High-dose interleukin-2 (HD-IL-2) bolus has been shown to obtain objective response rates ranging from 15% to 17% in patients with metastatic melanoma or renal cell carcinoma (RCC), with 6% to 8% of cases experiencing a durable complete response. However, HD-IL-2 is also associated with severe side-effects; if it is to remain a component of the curative treatment strategy in patients with metastatic melanoma or RCC, its therapeutic efficacy must be improved and patients who are most likely to benefit from treatment must be identified a priori. We designed a clinical study combining immunomodulating RT and HD-IL-2 to evaluate their clinical and immunological efficacy and to explore the predictive and prognostic value of 1) tumor-specific immune response and 2) serum levels of proangiogenic cytokines. METHODS/DESIGN: The primary endpoint of this proof-of-principle phase II study is immune response. Secondary endpoints are the identification of biomarkers potentially predictive of response, toxicity, response rate and overall survival. Three daily doses of booster radiotherapy (XRT) at 6-12 Gy will be administered to at least one metastatic field on days -3 to -1 before the first and third cycle. Treatment with IL-2 (dose 18 MIU/m2/day by continuous IV infusion for 72 hours) will start on day +1 and will be repeated every 3 weeks for up to 4 cycles and then every 4 weeks for a further 2 cycles. Immune response against tumor antigens expressed by melanoma and/or RCC will be evaluated during treatment. Circulating immune effectors and regulators, e.g. cytotoxic T lymphocytes and regulatory T cells, as well as serum levels of proangiogenic/proinflammatory cytokines will also be quantified. DISCUSSION: This study aims to evaluate the potential immunological synergism between HD-IL-2 and XRT, and to identify biomarkers that are predictive of response to IL-2 in order to spare potentially non responding patients from toxicity. TRIAL REGISTRATION: EudraCT no. 2012-001786-32.
72 schema:genre research_article
73 schema:inLanguage en
74 schema:isAccessibleForFree true
75 schema:isPartOf N1ba695c0b55841808bec8572e977900c
76 Nb552a4df00574443930875c5177a3474
77 sg:journal.1032886
78 schema:name Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
79 schema:pagination 262
80 schema:productId N4cca70c4943d42fbb544b96e9397f08d
81 N54b5f52c739d46589049925fa41f5f18
82 N7425b6a52032419e8bbb4c1fe647d054
83 Nb25eafd06b1a4b09ac911a1c0e2b2a2f
84 Nb8e32bebc86540a08c9a4880c382123d
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016280681
86 https://doi.org/10.1186/s12967-014-0262-6
87 schema:sdDatePublished 2019-04-11T13:07
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N7cbe1f1a388c4bac869e119040f2c5f0
90 schema:url http://link.springer.com/10.1186%2Fs12967-014-0262-6
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N142d433b7c6348a7905bdb4e07ddb2f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Biomarkers, Tumor
96 rdf:type schema:DefinedTerm
97 N1ba695c0b55841808bec8572e977900c schema:issueNumber 1
98 rdf:type schema:PublicationIssue
99 N274eff67bd1c4e58b563f49b8528a5ea rdf:first sg:person.0707623076.36
100 rdf:rest N4b3eb8dc466a45abb33ee225aab8442a
101 N2c6da7b9b7a24a5a82d040463a23c6d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Humans
103 rdf:type schema:DefinedTerm
104 N3a5d7b7cfb3c40b5a28d8f18f2b423c5 rdf:first sg:person.01033414110.50
105 rdf:rest N4a918968d7294208b74dd87ad9e7c2a5
106 N3bcebefe0f014a7b9e9d9c524afc2dd7 rdf:first sg:person.0660433404.23
107 rdf:rest Ne6b12200acff41899bce6c7e2e96414b
108 N4a918968d7294208b74dd87ad9e7c2a5 rdf:first sg:person.01050453536.03
109 rdf:rest Neafc82505988402fa2aeecfaac224d23
110 N4b3eb8dc466a45abb33ee225aab8442a rdf:first sg:person.0643034760.42
111 rdf:rest N3bcebefe0f014a7b9e9d9c524afc2dd7
112 N4cca70c4943d42fbb544b96e9397f08d schema:name dimensions_id
113 schema:value pub.1016280681
114 rdf:type schema:PropertyValue
115 N54b5f52c739d46589049925fa41f5f18 schema:name pubmed_id
116 schema:value 25245327
117 rdf:type schema:PropertyValue
118 N568d25d8c4f74a1596376701ec29254c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Neoplasm Metastasis
120 rdf:type schema:DefinedTerm
121 N5f414b0220b5465cb1e1c981f34bee70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Endpoint Determination
123 rdf:type schema:DefinedTerm
124 N67eaae53e5cd4ca9b4249da2f9722d67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Sample Size
126 rdf:type schema:DefinedTerm
127 N703f3c50072b464fb7caa9e0564a3c6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 N72dc1a4140784d3ab9c5899220ab5929 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Interleukin-2
132 rdf:type schema:DefinedTerm
133 N7425b6a52032419e8bbb4c1fe647d054 schema:name nlm_unique_id
134 schema:value 101190741
135 rdf:type schema:PropertyValue
136 N7cbe1f1a388c4bac869e119040f2c5f0 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 N910d2d1b41924526ad3a34020733c452 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Carcinoma, Renal Cell
140 rdf:type schema:DefinedTerm
141 N973eb2c5f71e45b79864670a75fa314e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Practice Guidelines as Topic
143 rdf:type schema:DefinedTerm
144 N988819765a204143b10050226df736dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Dose-Response Relationship, Immunologic
146 rdf:type schema:DefinedTerm
147 Na9ef8ad73ff44052b2e82018a679956e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Melanoma
149 rdf:type schema:DefinedTerm
150 Nb25eafd06b1a4b09ac911a1c0e2b2a2f schema:name readcube_id
151 schema:value 4d92fb5f788e886822218ed4c772e4965d2be8d5beac092fdcfa1382fd0d1a1d
152 rdf:type schema:PropertyValue
153 Nb552a4df00574443930875c5177a3474 schema:volumeNumber 12
154 rdf:type schema:PublicationVolume
155 Nb8e32bebc86540a08c9a4880c382123d schema:name doi
156 schema:value 10.1186/s12967-014-0262-6
157 rdf:type schema:PropertyValue
158 Nca76ae52ba0649c08b0027a3cd528641 rdf:first sg:person.01163341772.34
159 rdf:rest N3a5d7b7cfb3c40b5a28d8f18f2b423c5
160 Nda0c5a427d49467c935d3837c603cacc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Kidney Neoplasms
162 rdf:type schema:DefinedTerm
163 Ne6b12200acff41899bce6c7e2e96414b rdf:first sg:person.0603211266.70
164 rdf:rest rdf:nil
165 Neafc82505988402fa2aeecfaac224d23 rdf:first sg:person.01362577760.53
166 rdf:rest Nfa47abaa033447b69b54630824b95a23
167 Nfa47abaa033447b69b54630824b95a23 rdf:first sg:person.01020727237.88
168 rdf:rest N274eff67bd1c4e58b563f49b8528a5ea
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
173 schema:name Oncology and Carcinogenesis
174 rdf:type schema:DefinedTerm
175 sg:journal.1032886 schema:issn 1479-5876
176 schema:name Journal of Translational Medicine
177 rdf:type schema:Periodical
178 sg:person.01020727237.88 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
179 schema:familyName Valmorri
180 schema:givenName Linda
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020727237.88
182 rdf:type schema:Person
183 sg:person.01033414110.50 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
184 schema:familyName de Rosa
185 schema:givenName Francesco
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033414110.50
187 rdf:type schema:Person
188 sg:person.01050453536.03 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
189 schema:familyName Ridolfi
190 schema:givenName Ruggero
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03
192 rdf:type schema:Person
193 sg:person.01163341772.34 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
194 schema:familyName Ridolfi
195 schema:givenName Laura
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163341772.34
197 rdf:type schema:Person
198 sg:person.01362577760.53 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
199 schema:familyName Gentili
200 schema:givenName Giorgia
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362577760.53
202 rdf:type schema:Person
203 sg:person.0603211266.70 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
204 schema:familyName Guidoboni
205 schema:givenName Massimo
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603211266.70
207 rdf:type schema:Person
208 sg:person.0643034760.42 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
209 schema:familyName Parisi
210 schema:givenName Elisabetta
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643034760.42
212 rdf:type schema:Person
213 sg:person.0660433404.23 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
214 schema:familyName Romeo
215 schema:givenName Antonino
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660433404.23
217 rdf:type schema:Person
218 sg:person.0707623076.36 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
219 schema:familyName Scarpi
220 schema:givenName Emanuela
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707623076.36
222 rdf:type schema:Person
223 sg:pub.10.1038/ni1102-991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013709887
224 https://doi.org/10.1038/ni1102-991
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/nri1961 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034368267
227 https://doi.org/10.1038/nri1961
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/sj.cdd.4402148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035848769
230 https://doi.org/10.1038/sj.cdd.4402148
231 rdf:type schema:CreativeWork
232 sg:pub.10.1046/j.1440-1711.1999.00824.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032221856
233 https://doi.org/10.1046/j.1440-1711.1999.00824.x
234 rdf:type schema:CreativeWork
235 sg:pub.10.1186/1479-5876-11-54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049399339
236 https://doi.org/10.1186/1479-5876-11-54
237 rdf:type schema:CreativeWork
238 sg:pub.10.1186/1479-5876-9-204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002969174
239 https://doi.org/10.1186/1479-5876-9-204
240 rdf:type schema:CreativeWork
241 https://app.dimensions.ai/details/publication/pub.1074593980 schema:CreativeWork
242 https://app.dimensions.ai/details/publication/pub.1074593989 schema:CreativeWork
243 https://app.dimensions.ai/details/publication/pub.1075012417 schema:CreativeWork
244 https://app.dimensions.ai/details/publication/pub.1078776563 schema:CreativeWork
245 https://app.dimensions.ai/details/publication/pub.1079645830 schema:CreativeWork
246 https://app.dimensions.ai/details/publication/pub.1082996261 schema:CreativeWork
247 https://doi.org/10.1002/(sici)1097-0142(19960101)77:1<89::aid-cncr15>3.0.co;2-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049715364
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1015678740
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1002732031
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.ijrobp.2003.09.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028641767
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.ijrobp.2005.06.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052313527
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.immuni.2007.02.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002629248
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.jaci.2009.09.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012815377
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.smim.2010.03.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017765338
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0065-2776(06)92005-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014165029
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0360-3016(02)03748-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053539797
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s1471-4906(01)01860-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007002305
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1038/sj.embor.7401099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028445502
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1053/j.seminoncol.2006.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042465078
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1056/nejmoa1002011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012824919
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1056/nejmoa1103782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041864150
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1073/pnas.86.24.10104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025542654
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1080/09553000701481816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051306626
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1089/1084978041424972 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059207859
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1093/jnci/djs629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007220641
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1097/00000658-199809000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060134855
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1097/00002371-200107000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013282290
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1097/01.cji.0000177999.95831.7b schema:sameAs https://app.dimensions.ai/details/publication/pub.1035482259
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1111/j.1464-410x.2008.07435.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020644032
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1126/science.276.5316.1268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062556793
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1146/annurev.immunol.26.021607.090357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039191682
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1158/0008-5472.can-04-1525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003315567
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1158/1078-0432.ccr-06-1872 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025832682
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1158/1078-0432.ccr-09-1624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028571226
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1158/1078-0432.ccr-12-3080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021277346
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1177/1758834012443725 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064077302
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1200/jco.1991.9.7.1233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078157437
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1200/jco.1995.13.3.688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082550218
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1200/jco.1999.17.7.2105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549817
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1200/jco.2005.03.6830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045493910
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1200/jco.2008.19.1106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005654736
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1200/jco.2008.20.0766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006224899
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1200/jco.2008.21.1540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032602654
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1667/rr3196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068196266
322 rdf:type schema:CreativeWork
323 https://doi.org/10.2174/1381612023394089 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069164659
324 rdf:type schema:CreativeWork
325 https://doi.org/10.2307/3578216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070380764
326 rdf:type schema:CreativeWork
327 https://doi.org/10.3816/cgc.2005.n.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043681253
328 rdf:type schema:CreativeWork
329 https://www.grid.ac/institutes/grid.419563.c schema:alternateName Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
330 schema:name Immunotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy
331 Radiotherapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
332 Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
333 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...